An internal standard for the quantification of levetiracetam
Related Products
Unlabeled Version(s)
9001820Levetiracetam
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Levetiracetam-d6

Item No. 26457

Technical Information
Formal Name
αS-α-ethyl-5-oxo-1-pyrrolidine-2,2,3,3,4,4-d6-acetamide
CAS Number
1133229-30-7
Synonyms
  • (S)-Levetiracetam-d6
Molecular Formula
C8H8D6N2O2
Formula Weight
Purity
≥99% deuterated forms (d1-d6)
Formulation
A solid
Acetone: slightly soluble, sonicatedChloroform: slightly soluble
SMILES
NC([C@H](CC)N1C(C([2H])([2H])C([2H])([2H])C1([2H])[2H])=O)=O
InChi Code
InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1/i3D2,4D2,5D2
InChi Key
HPHUVLMMVZITSG-QXMLZOKMSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Product Description

    Levetiracetam-d6 is intended for use as an internal standard for the quantification of levetiracetam (Item No. 9001820) by GC- or LC-MS. Levetiracetam is an antiepileptic agent that binds to the synaptic vesicle protein SV2A (IC50 = 1.99 μM).1 In vivo, levetiracetam suppresses seizures in fully kindled rats.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Lynch, B.A., Lamberg, N., Nocka, K., et alThe synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc. Natl. Acad. Sci. USA 101(26), 9861-9866 (2004).

    2. Löscher, W., and Brandt, C. Prevention or modification of epileptogenesis after brain insults: Experimental approaches and translational research. Pharmacol. Rev. 62(4), 668-700 (2010).